THE KINETICS AND TEMPORAL EXPRESSION OF T-CELL ACTIVATION-ASSOCIATED ANTIGENS CD15 (LEUM1), CD30 (KI-1), EMA, AND CD11C (LEUM5) BY BENIGN ACTIVATED T-CELLS

被引:0
|
作者
CHADBURN, A
INGHIRAMI, G
KNOWLES, DM
机构
关键词
T-CELLS; ACTIVATION ANTIGENS; FLOW CYTOMETRY; MONOCLONAL ANTIBODIES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cell surface antigens, including CD71 (T9), CD38 (T10), HLA-DR, CD25 (IL2-R), CD15 (LeuM1), CD30 (Ki-1), epithelial membrane antigen (EMA), and CD11c (LeuM5), have been identified on the surface of neoplastic T-cells. The significance of this expression is unknown since the expression of these antigens by benign T cells has not been fully investigated. In this study the kinetics, temporal relation and hierarchy of expression of these eight cell surface antigens by purified normal peripheral blood T cells following activation with phytohemagglutinin (PHA) were investigated using one- and two-color flow cytometry. All eight antigens were expressed in a hierarchical manner following activation of normal peripheral blood T cells with PHA. The sequence of antigen expression and the initial time point of this expression was: CD38, < 24 h; CD71, CD25, 24 h; EMA, HLA-DR, CD15, 48-72 h; CD30, 72 h; and CD11c, 96-120 h. The maximum percentage of T cells expressing each antigen and the time point of maximum expression was: CD38 96 % at 14 and 1 7 days; CD 71 88 %, CD25 94 %, EMA 55 %, and CD30 31 % at 96 h; CD]5 56% at 120 h; HLA-DR 30% at 168 h; and CD11c 42% at 240 h. The expression of these 8 antigens clustered into six distinct immunophenotypic constellations; Group I: None; Group II: CD38 with CD71 and/or CD25; Group III: CD38, CD71, CD25 with HLA-DR, CD15 and/or EMA; Group IV: CD38, CD71, CD25, EMA, HLA-DR with CD15, CD30 and/or CD11c; Group V. CD38, CD25, CD11c with CD71, EMA and/or HLA-DR; Group VI: CD38 with CD25 and/or CD11c. Finally, EMA and CD11c were preferentially expressed by CD4 and CD8 T cells, respectively. In summary, these results demonstrate that all eight antigens (1) are associated with T-cell activation, (2) are expressed in a hierarchical manner following activation, and (3) that this expression clusters into distinct immunophenotypic constellations.
引用
收藏
页码:193 / 202
页数:10
相关论文
共 10 条
  • [1] HAIRY-CELL LEUKEMIA-ASSOCIATED ANTIGEN LEUM5 (CD11C) IS PREFERENTIALLY EXPRESSED BY BENIGN ACTIVATED AND NEOPLASTIC CD8 T-CELLS
    CHADBURN, A
    INGHIRAMI, G
    KNOWLES, DM
    AMERICAN JOURNAL OF PATHOLOGY, 1990, 136 (01): : 29 - 37
  • [2] CD30 (KI-1) EXPRESSION IN ADULT T-CELL LEUKEMIA-LYMPHOMA IS ASSOCIATED WITH DISTINCTIVE IMMUNOHISTOLOGICAL AND CLINICAL CHARACTERISTICS
    TAKESHITA, M
    AKAMATSU, M
    OHSHIMA, K
    KOBARI, S
    KIKUCHI, M
    SUZUMIYA, J
    UIKE, N
    OKAMURA, T
    HISTOPATHOLOGY, 1995, 26 (06) : 539 - 546
  • [3] PROGNOSTIC-SIGNIFICANCE OF CD30 (KI-1/BER-H2) EXPRESSION IN PRIMARY CUTANEOUS LARGE CELL LYMPHOMAS OF T-CELL ORIGIN
    WILLEMZE, R
    BELJAARDS, RC
    MEIJER, CJLM
    VANVLOTEN, WA
    TOONSTRA, J
    VANDERPUTTE, SCJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (03) : 542 - 542
  • [4] PROGNOSTIC-SIGNIFICANCE OF CD30 (KI-1/BER-H2) EXPRESSION IN PRIMARY CUTANEOUS LARGE CELL LYMPHOMAS OF T-CELL ORIGIN
    WILLEMZE, R
    BELJAARDS, RC
    MEIJER, CJLM
    VANVLOTEN, WA
    TOONSTRA, J
    VANDERPUTTE, SCJ
    CLINICAL RESEARCH, 1989, 37 (02): : A770 - A770
  • [5] PROGNOSTIC-SIGNIFICANCE OF CD30 (KI-1/BER-H2) EXPRESSION IN PRIMARY CUTANEOUS LARGE-CELL LYMPHOMAS OF T-CELL ORIGIN - A CLINICOPATHOLOGIC AND IMMUNOHISTOCHEMICAL STUDY IN 20 PATIENTS
    BELJAARDS, RC
    MEIJER, CJLM
    SCHEFFER, E
    TOONSTRA, J
    VANVLOTEN, WA
    VANDERPUTTE, SCJ
    GEERTS, ML
    WILLEMZE, R
    AMERICAN JOURNAL OF PATHOLOGY, 1989, 135 (06): : 1169 - 1178
  • [6] DIFFERENCES BETWEEN PRIMED ALLOGENEIC T-CELL RESPONSES AND THE PRIMARY MIXED LEUKOCYTE REACTION - PRIMED T-CELLS BECOME INDEPENDENT OF THE BLOCKING EFFECTS OF MONOCLONAL-ANTIBODIES AGAINST IL-1-BETA AND THE CD5, CD11A (LFA-1), AND CD11C (P 150,95) MOLECULES
    ODUM, N
    HOFMANN, B
    MORLING, N
    PLATZ, P
    RYDER, LP
    TVEDE, N
    GEISLER, C
    SVEJGAARD, A
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 27 (04) : 405 - 411
  • [7] INDUCTION OF HOMOTYPIC T-CELL ADHESION BY TRIGGERING OF LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1-ALPHA (CD11A) - DIFFERENTIAL-EFFECTS ON RESTING AND ACTIVATED T-CELLS
    KOOPMAN, G
    DEGRAAFF, M
    HUYSMANS, ACLM
    MEIJER, CJLM
    PALS, ST
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (07) : 1851 - 1856
  • [8] KI-1 (CD30) POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMA OF T-CELL PHENOTYPE DEVELOPING IN ASSOCIATION WITH LONGSTANDING TUBERCULOUS PYOTHORAX - REPORT OF A CASE WITH DETECTION OF EPSTEIN-BARR-VIRUS GENOME IN THE TUMOR-CELLS
    NAKAMURA, S
    SASAJIMA, Y
    KOSHIKAWA, T
    KITOH, K
    KATO, M
    UEDA, R
    MORI, S
    SUCHI, T
    HUMAN PATHOLOGY, 1995, 26 (12) : 1382 - 1385
  • [9] A KI-1 (CD30)-POSITIVE HUMAN CELL-LINE (KARPAS-299) ESTABLISHED FROM A HIGH-GRADE NON-HODGKINS LYMPHOMA, SHOWING A 2-5 TRANSLOCATION AND REARRANGEMENT OF THE T-CELL RECEPTOR BETA-CHAIN GENE
    FISCHER, P
    NACHEVA, E
    MASON, DY
    SHERRINGTON, PD
    HOYLE, C
    HAYHOE, FGJ
    KARPAS, A
    BLOOD, 1988, 72 (01) : 234 - 240
  • [10] INTERCELLULAR-ADHESION MOLECULE-2, A 2ND COUNTER-RECEPTOR FOR CD11A/CD18 (LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1), PROVIDES A COSTIMULATORY SIGNAL FOR T-CELL RECEPTOR-INITIATED ACTIVATION OF HUMAN T-CELLS
    DAMLE, NK
    KLUSSMAN, K
    ARUFFO, A
    JOURNAL OF IMMUNOLOGY, 1992, 148 (03): : 665 - 671